Raymond James Financial Inc. purchased a new stake in Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,583,284 shares of the company’s stock, valued at approximately $54,813,000. Raymond James Financial Inc. owned approximately 9.15% of Columbia Research Enhanced Core ETF at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the stock. LPL Financial LLC raised its position in Columbia Research Enhanced Core ETF by 51.3% in the 3rd quarter. LPL Financial LLC now owns 5,984,602 shares of the company’s stock valued at $202,938,000 after purchasing an additional 2,029,508 shares in the last quarter. Stratos Investment Management LLC raised its position in Columbia Research Enhanced Core ETF by 47.2% in the 4th quarter. Stratos Investment Management LLC now owns 1,410,831 shares of the company’s stock valued at $48,843,000 after purchasing an additional 452,426 shares in the last quarter. Amplius Wealth Advisors LLC raised its position in Columbia Research Enhanced Core ETF by 11.0% in the 4th quarter. Amplius Wealth Advisors LLC now owns 1,351,246 shares of the company’s stock valued at $46,780,000 after purchasing an additional 134,212 shares in the last quarter. BlueStem Wealth Partners LLC acquired a new stake in Columbia Research Enhanced Core ETF in the 4th quarter valued at about $41,438,000. Finally, Stratos Wealth Partners LTD. raised its position in Columbia Research Enhanced Core ETF by 1.9% in the 4th quarter. Stratos Wealth Partners LTD. now owns 1,154,334 shares of the company’s stock valued at $39,963,000 after purchasing an additional 21,711 shares in the last quarter.
Columbia Research Enhanced Core ETF Stock Performance
Shares of NYSEARCA RECS opened at $33.29 on Tuesday. Columbia Research Enhanced Core ETF has a fifty-two week low of $29.41 and a fifty-two week high of $36.60. The firm has a market capitalization of $1.76 billion, a PE ratio of 23.97 and a beta of 0.94. The stock’s 50-day simple moving average is $35.22 and its 200-day simple moving average is $34.78.
Columbia Research Enhanced Core ETF Profile
The Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting. RECS was launched on Sep 25, 2019 and is managed by Columbia.
See Also
- Five stocks we like better than Columbia Research Enhanced Core ETF
- How to Invest in Small Cap StocksĀ
- How to Protect Your Portfolio When Inflation Is Rising
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding RECS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Core ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Core ETF and related companies with MarketBeat.com's FREE daily email newsletter.